COVID-19 Impact on Global Thrombolytic Drug Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: CA5947FE9DDDEN
QYResearch

Abstracts

This report focuses on the global Thrombolytic Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thrombolytic Drug development in North America, Europe, China and Japan.
The key players covered in this study

• Roche
• Sedico Pharmaceuticals
• Eumedica
• Genentech
• Microbix
• Medac
• Mochida Pharmaceutical
• Taj Pharmaceuticals
• Wulfing Pharma GmbH

Market segment by Type, the product can be split into

• Fibrin Specific Drugs
• Nonfibrin-specific Drugs

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacies
• Electronic Pharmacy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Thrombolytic Drug status, future forecast, growth opportunity, key market and key players.
• To present the Thrombolytic Drug development in North America, Europe, China and Japan.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Thrombolytic Drug are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Thrombolytic Drug Revenue
1.4 Market Analysis by Type
  1.4.1 Global Thrombolytic Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fibrin Specific Drugs
  1.4.3 Nonfibrin-specific Drugs
1.5 Market by Application
  1.5.1 Global Thrombolytic Drug Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacies
  1.5.4 Electronic Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Thrombolytic Drug Industry Impact
  1.6.1 How the Covid-19 is Affecting the Thrombolytic Drug Industry
    1.6.1.1 Thrombolytic Drug Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Thrombolytic Drug Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Thrombolytic Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Thrombolytic Drug Market Perspective (2015-2026)
2.2 Thrombolytic Drug Growth Trends by Regions
  2.2.1 Thrombolytic Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Thrombolytic Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Thrombolytic Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Thrombolytic Drug Market Growth Strategy
  2.3.6 Primary Interviews with Key Thrombolytic Drug Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Thrombolytic Drug Players by Market Size
  3.1.1 Global Top Thrombolytic Drug Players by Revenue (2015-2020)
  3.1.2 Global Thrombolytic Drug Revenue Market Share by Players (2015-2020)
  3.1.3 Global Thrombolytic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Thrombolytic Drug Market Concentration Ratio
  3.2.1 Global Thrombolytic Drug Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Thrombolytic Drug Revenue in 2019
3.3 Thrombolytic Drug Key Players Head office and Area Served
3.4 Key Players Thrombolytic Drug Product Solution and Service
3.5 Date of Enter into Thrombolytic Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Thrombolytic Drug Historic Market Size by Type (2015-2020)
4.2 Global Thrombolytic Drug Forecasted Market Size by Type (2021-2026)

5 THROMBOLYTIC DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Thrombolytic Drug Market Size by Application (2015-2020)
5.2 Global Thrombolytic Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Thrombolytic Drug Market Size (2015-2020)
6.2 Thrombolytic Drug Key Players in North America (2019-2020)
6.3 North America Thrombolytic Drug Market Size by Type (2015-2020)
6.4 North America Thrombolytic Drug Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Thrombolytic Drug Market Size (2015-2020)
7.2 Thrombolytic Drug Key Players in Europe (2019-2020)
7.3 Europe Thrombolytic Drug Market Size by Type (2015-2020)
7.4 Europe Thrombolytic Drug Market Size by Application (2015-2020)

8 CHINA

8.1 China Thrombolytic Drug Market Size (2015-2020)
8.2 Thrombolytic Drug Key Players in China (2019-2020)
8.3 China Thrombolytic Drug Market Size by Type (2015-2020)
8.4 China Thrombolytic Drug Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Thrombolytic Drug Market Size (2015-2020)
9.2 Thrombolytic Drug Key Players in Japan (2019-2020)
9.3 Japan Thrombolytic Drug Market Size by Type (2015-2020)
9.4 Japan Thrombolytic Drug Market Size by Application (2015-2020)

10 KEY PLAYERS PROFILES

10.1 Roche
  10.1.1 Roche Company Details
  10.1.2 Roche Business Overview and Its Total Revenue
  10.1.3 Roche Thrombolytic Drug Introduction
  10.1.4 Roche Revenue in Thrombolytic Drug Business (2015-2020))
  10.1.5 Roche Recent Development
10.2 Sedico Pharmaceuticals
  10.2.1 Sedico Pharmaceuticals Company Details
  10.2.2 Sedico Pharmaceuticals Business Overview and Its Total Revenue
  10.2.3 Sedico Pharmaceuticals Thrombolytic Drug Introduction
  10.2.4 Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business (2015-2020)
  10.2.5 Sedico Pharmaceuticals Recent Development
10.3 Eumedica
  10.3.1 Eumedica Company Details
  10.3.2 Eumedica Business Overview and Its Total Revenue
  10.3.3 Eumedica Thrombolytic Drug Introduction
  10.3.4 Eumedica Revenue in Thrombolytic Drug Business (2015-2020)
  10.3.5 Eumedica Recent Development
10.4 Genentech
  10.4.1 Genentech Company Details
  10.4.2 Genentech Business Overview and Its Total Revenue
  10.4.3 Genentech Thrombolytic Drug Introduction
  10.4.4 Genentech Revenue in Thrombolytic Drug Business (2015-2020)
  10.4.5 Genentech Recent Development
10.5 Microbix
  10.5.1 Microbix Company Details
  10.5.2 Microbix Business Overview and Its Total Revenue
  10.5.3 Microbix Thrombolytic Drug Introduction
  10.5.4 Microbix Revenue in Thrombolytic Drug Business (2015-2020)
  10.5.5 Microbix Recent Development
10.6 Medac
  10.6.1 Medac Company Details
  10.6.2 Medac Business Overview and Its Total Revenue
  10.6.3 Medac Thrombolytic Drug Introduction
  10.6.4 Medac Revenue in Thrombolytic Drug Business (2015-2020)
  10.6.5 Medac Recent Development
10.7 Mochida Pharmaceutical
  10.7.1 Mochida Pharmaceutical Company Details
  10.7.2 Mochida Pharmaceutical Business Overview and Its Total Revenue
  10.7.3 Mochida Pharmaceutical Thrombolytic Drug Introduction
  10.7.4 Mochida Pharmaceutical Revenue in Thrombolytic Drug Business (2015-2020)
  10.7.5 Mochida Pharmaceutical Recent Development
10.8 Taj Pharmaceuticals
  10.8.1 Taj Pharmaceuticals Company Details
  10.8.2 Taj Pharmaceuticals Business Overview and Its Total Revenue
  10.8.3 Taj Pharmaceuticals Thrombolytic Drug Introduction
  10.8.4 Taj Pharmaceuticals Revenue in Thrombolytic Drug Business (2015-2020)
  10.8.5 Taj Pharmaceuticals Recent Development
10.9 Wulfing Pharma GmbH
  10.9.1 Wulfing Pharma GmbH Company Details
  10.9.2 Wulfing Pharma GmbH Business Overview and Its Total Revenue
  10.9.3 Wulfing Pharma GmbH Thrombolytic Drug Introduction
  10.9.4 Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business (2015-2020)
  10.9.5 Wulfing Pharma GmbH Recent Development

11 ANALYST'S VIEWPOINTS/CONCLUSIONS

12 APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Thrombolytic Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Thrombolytic Drug Revenue
Table 3. Ranking of Global Top Thrombolytic Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Thrombolytic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fibrin Specific Drugs
Table 6. Key Players of Nonfibrin-specific Drugs
Table 7. COVID-19 Impact Global Market: (Four Thrombolytic Drug Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Thrombolytic Drug Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Thrombolytic Drug Players to Combat Covid-19 Impact
Table 12. Global Thrombolytic Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Thrombolytic Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Thrombolytic Drug Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Thrombolytic Drug Market Share by Regions (2015-2020)
Table 16. Global Thrombolytic Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Thrombolytic Drug Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Thrombolytic Drug Market Growth Strategy
Table 22. Main Points Interviewed from Key Thrombolytic Drug Players
Table 23. Global Thrombolytic Drug Revenue by Players (2015-2020) (Million US$)
Table 24. Global Thrombolytic Drug Market Share by Players (2015-2020)
Table 25. Global Top Thrombolytic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombolytic Drug as of 2019)
Table 26. Global Thrombolytic Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Thrombolytic Drug Product Solution and Service
Table 29. Date of Enter into Thrombolytic Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Thrombolytic Drug Market Size by Type (2015-2020) (Million US$)
Table 32. Global Thrombolytic Drug Market Size Share by Type (2015-2020)
Table 33. Global Thrombolytic Drug Revenue Market Share by Type (2021-2026)
Table 34. Global Thrombolytic Drug Market Size Share by Application (2015-2020)
Table 35. Global Thrombolytic Drug Market Size by Application (2015-2020) (Million US$)
Table 36. Global Thrombolytic Drug Market Size Share by Application (2021-2026)
Table 37. North America Key Players Thrombolytic Drug Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Thrombolytic Drug Market Share (2019-2020)
Table 39. North America Thrombolytic Drug Market Size by Type (2015-2020) (Million US$)
Table 40. North America Thrombolytic Drug Market Share by Type (2015-2020)
Table 41. North America Thrombolytic Drug Market Size by Application (2015-2020) (Million US$)
Table 42. North America Thrombolytic Drug Market Share by Application (2015-2020)
Table 43. Europe Key Players Thrombolytic Drug Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Thrombolytic Drug Market Share (2019-2020)
Table 45. Europe Thrombolytic Drug Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Thrombolytic Drug Market Share by Type (2015-2020)
Table 47. Europe Thrombolytic Drug Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Thrombolytic Drug Market Share by Application (2015-2020)
Table 49. China Key Players Thrombolytic Drug Revenue (2019-2020) (Million US$)
Table 50. China Key Players Thrombolytic Drug Market Share (2019-2020)
Table 51. China Thrombolytic Drug Market Size by Type (2015-2020) (Million US$)
Table 52. China Thrombolytic Drug Market Share by Type (2015-2020)
Table 53. China Thrombolytic Drug Market Size by Application (2015-2020) (Million US$)
Table 54. China Thrombolytic Drug Market Share by Application (2015-2020)
Table 55. Japan Key Players Thrombolytic Drug Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Thrombolytic Drug Market Share (2019-2020)
Table 57. Japan Thrombolytic Drug Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Thrombolytic Drug Market Share by Type (2015-2020)
Table 59. Japan Thrombolytic Drug Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Thrombolytic Drug Market Share by Application (2015-2020)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Product
Table 64. Roche Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 65. Roche Recent Development
Table 66. Sedico Pharmaceuticals Company Details
Table 67. Sedico Pharmaceuticals Business Overview
Table 68. Sedico Pharmaceuticals Product
Table 69. Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 70. Sedico Pharmaceuticals Recent Development
Table 71. Eumedica Company Details
Table 72. Eumedica Business Overview
Table 73. Eumedica Product
Table 74. Eumedica Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 75. Eumedica Recent Development
Table 76. Genentech Company Details
Table 77. Genentech Business Overview
Table 78. Genentech Product
Table 79. Genentech Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 80. Genentech Recent Development
Table 81. Microbix Company Details
Table 82. Microbix Business Overview
Table 83. Microbix Product
Table 84. Microbix Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 85. Microbix Recent Development
Table 86. Medac Company Details
Table 87. Medac Business Overview
Table 88. Medac Product
Table 89. Medac Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 90. Medac Recent Development
Table 91. Mochida Pharmaceutical Company Details
Table 92. Mochida Pharmaceutical Business Overview
Table 93. Mochida Pharmaceutical Product
Table 94. Mochida Pharmaceutical Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 95. Mochida Pharmaceutical Recent Development
Table 96. Taj Pharmaceuticals Business Overview
Table 97. Taj Pharmaceuticals Product
Table 98. Taj Pharmaceuticals Company Details
Table 99. Taj Pharmaceuticals Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 100. Taj Pharmaceuticals Recent Development
Table 101. Wulfing Pharma GmbH Company Details
Table 102. Wulfing Pharma GmbH Business Overview
Table 103. Wulfing Pharma GmbH Product
Table 104. Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business (2015-2020) (Million US$)
Table 105. Wulfing Pharma GmbH Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Thrombolytic Drug Market Share by Type: 2020 VS 2026
Figure 2. Fibrin Specific Drugs Features
Figure 3. Nonfibrin-specific Drugs Features
Figure 4. Global Thrombolytic Drug Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Electronic Pharmacy Case Studies
Figure 8. Thrombolytic Drug Report Years Considered
Figure 9. Global Thrombolytic Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Thrombolytic Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global Thrombolytic Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Thrombolytic Drug Market Share by Players in 2019
Figure 14. Global Top Thrombolytic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombolytic Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Thrombolytic Drug Revenue in 2019
Figure 16. North America Thrombolytic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Thrombolytic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Thrombolytic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Thrombolytic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Roche Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 22. Sedico Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Sedico Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 24. Eumedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Eumedica Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 26. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Genentech Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 28. Microbix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Microbix Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 30. Medac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Medac Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 32. Mochida Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Mochida Pharmaceutical Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 34. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Taj Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 36. Wulfing Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Wulfing Pharma GmbH Revenue Growth Rate in Thrombolytic Drug Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed